VLA
Click for more information
0.00% $1.75 viralytics limited

I'm pretty sure that it would not be in Merck's best interest to...

  1. DavieJones
    250 Posts.
    lightbulb Created with Sketch. 27
    clock Created with Sketch.
    06/01/17
    13:45
    Post #: 21722930

    I'm pretty sure that it would not be in Merck's best interest to present anything from the STORM/KEYNOTE trial. Why give a leg-up to potential bidders / competitors ? Merck will be keen to keep all of the results hushed up until they are prepared to licence/partner/acquire the technology if the trial is successful.

    .
    VLA Price at posting: $1.21 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Trump is President Again: What Does This Mean for Crypto?
right-arrow Created with Sketch.
NEWS Update on the ASX' most anticipated drill campaign
right-arrow Created with Sketch.
NEWS Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive
right-arrow Created with Sketch.
3DA To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels
right-arrow Created with Sketch.
EQN Equinox Resources reports outstanding naturally occurring antimony grade at Alturas Project
right-arrow Created with Sketch.
NEWS HotCopper Highlights: Your most watched and most discussed stocks this week
right-arrow Created with Sketch.
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.